11 Most Profitable Companies In The Fortune 500

Page 7 of 12

#5 Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) reported net income of $18.1 billion for its fiscal year, up almost 50% year-over-year. Sales rocketed up 31.1% year-over-year due in large part to the company’s Hep C franchise – Sovaldi and Harvoni. Despite trading for unde 9 times forward earnings estimates, shares are down 7% year-to-date as some traders worry about future competition.

Follow Gilead Sciences Inc. (NASDAQ:GILD)

wavebreakmedia/Shutterstock.com

wavebreakmedia/Shutterstock.com

Page 7 of 12